Medicine Overview of Boletraaz Tablet
Weakness, Sinus inflammation, Infection, Fever, Cough, Fatigue, Stomatitis (Inflammation of the mouth), Otitis media (infection of ear), Diarrhoea, Upper respiratory tract infection.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Boletraaz 10mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Boletraaz 10mg Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
In Depth Information on Boletraaz Tablet
- Do not start everolimus and consult your doctor if you have liver problems, diabetes, high blood cholesterol, had a recent surgery or have unhealed wound after surgery, have infection, previously had hepatitis, are pregnant or breast-feeding or have intolerance to some sugars.
- Seek medical advice if you have increased thirst or increased frequency of urination, if you get any infection, suffer from shortness of breath, cough or fever, need to receive any vaccination after taking everolimus.
- Everolimus may affect male or female fertility; consult your doctor if you are planning to have a child.
- Do not drive or operate machinery while taking everolimus as it may cause fatigue.
Boletraaz Tablet related warnings
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Boletraaz 10mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Boletraaz 10mg Tablet is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well.
As fatigue is a common side effect with Boletraaz 10mg Tablet and this may affect your ability to drive
Boletraaz 10mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Boletraaz 10mg Tablet is recommended.
Boletraaz 10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Boletraaz 10mg Tablet may be needed. Please consult your doctor.
Use of Boletraaz 10mg Tablet is not recommended in patients with severe liver disease.
Frequently asked questions about Boletraaz Tablet
Boletraaz is a targeted therapy drug (mTOR inhibitor) and not a traditional chemotherapeutic agent
Boletraaz is not cytotoxic, it is a biological therapy for breast cancer
Boletraaz is administered 10 mg once daily orally as tablet with a glass of water
Generally Boletraaz works for about 30 hours, however it may depend on the individual taking the medicine.
One of the following vendor pharmacies will deliver Boletraaz 10mg Tablet: RUS, SAF, BAP, SVH, PWN, SGH, GTC, GPT, ARD, IPL, SDM, HBV, MAX, HSP, PMA, BTM, SHP, RPI, 9T9, PEN, AGT, SBL, HEX, P2P, NSL, DFP, EMB, WHL, INC, PLT, SSA, DGN, VDH, EQN, JIV, SWA, RPP, UMP, VNS, ZEL, JSL, TRP, SLN, RWP, THP, NTB, ZVP, IAD, SWP, HTS, DPL, NVY, BAL, OWP, SHD, AAR, LCC, BMJ, ANT, BDN, GNC, BBS, JVO, ATL, GBL, BSN, TNH, MMS, USF, DYG, EVP, TFP, ADT, DLP, OLT, MLC, CHP, KHH, KMC, NVL, PVP, ATP, NAS, OIP, MAK, DPP, BLE, RHL, MPC, PNT, SBA, GHR, HZF, AYU, RKS, KHC, HGI, BHP, PTI, AAY, MDH, DVH, SJP, MSD, SHC, SRG, RJH, AYM, SYN, SGC, RSS, HPC, VRS, NNH, PRN, LHA, CLT, SPD, MAM, ESY, OHM, QTM, WSI, DAO, TOM, SCH, HNP, GTK, GPP, SVS, ENP, BHM, HAT, MDO, DHR, FGH, QLF, PPR, NDP, RDR, HMP, STA, BIO, RSA, RDH, AMR, ABP, RHW, JVN, HIP, NXG